Merck Sharp & Dohme LLC Contracts with Department of Health and Human Services
Relationship Overview
Total Contract Value: $5,027,422,510
Contract Count: 12
Average Contract Size: $419.0M
Sole Source Rate: 0%
Small Business Rate: 0%
Spending by Sector
- Other: $5.0B (12 contracts)
Contracts
- VSCCINE FOR CHILDREN (VFC) 2014 — $1.5B
- IGF::OT::IGF 2017 VACCINES FOR CHILDREN — $1.5B
- VACCINE FOR CHILDREN 2013 — $1.4B
- IGF::OT::IGF — $236.3M
- ERVEBO PROCUREMENT — $155.8M
- ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES — $102.3M
- IGF::OT::IGF FOR OTHER FUNCTIONS — $77.9M
- BPS - ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR. IGF::OT::IGF — $65.1M
- VACCINES FOR ADULTS — $29.5M
- VACCINES FOR ADULTS 2014 — $24.0M
- VACCINE FOR ADULT 2013 — $23.2M
- VACCINE STORAGE AND ROTATION, 2021-2026 — $6.4M
Frequently Asked Questions
How many contracts does Merck Sharp & Dohme LLC have with Department of Health and Human Services?
Merck Sharp & Dohme LLC has 12 contracts with Department of Health and Human Services worth a combined $5.0B.
What is the average contract size between Merck Sharp & Dohme LLC and Department of Health and Human Services?
The average contract size is $419.0M.
What percentage of Merck Sharp & Dohme LLC's contracts with Department of Health and Human Services are sole-source?
0% of the contracts are sole-source awards.